CETP and cardiovascular disorder: In several clinical studies, it has not been proven that elevating HDL cholesterol (for instance, with niacin or CETP suppression) enhances CVD outcomes, and randomized Mendelian studies also show that levels of HDL-C are not prognostic for cardiovascular disease events.